Acute pancreatitis in dogs

Journal of Veterinary Emergency and Critical Care

Volumn 13, Issue 4, 2003, Pages 201-213

  Holm, Jennifer L ^a   Chan, Daniel L ^a   Rozanski, Elizabeth A ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

Canine; Diagnostic imaging; Illness severity markers; Scoring schemes; Therapy

Indexed keywords

EID: 14944341505     PISSN: 14793261     EISSN: 14764431     Source Type: Journal    
DOI: 10.1111/j.1534-6935.2003.00113.x     Document Type: Article

References (139)

1. Dervenis C, Johnson CD, Bassi C, et al. Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini Consensus Conference. Int J Pancreatol 1999; 25 (3): 195 – 210.pmid/10453421
2. Banerjee AK, Kaul A, Bache E, et al. An audit of fatal acute pancreatitis. Postgrad Med J 1995; 71 (838): 472 – 475.pmid/7567753
3. Bradley EL. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, GA. Septemeber 11–13, 1992. Arch Surg 1993; 128 (5): 586 – 590.pmid/8489394
4. Isenmann R, Rau B, Beger HG. Bacterial infection and extent of necrosis are determinants of organ failure in patients with acute necrotizing pancreatitis. Br J Surg 1999; 86 (8): 1020 – 1024.pmid/10460637
5. Vensentini S, Bassi C, Talamini G, et al. Prospective comparison of C-reactive protein level, Ranson score, and contrast enhanced computed tomography in the prediction of septic complications of acute pancreatitis. Br J Surg 1993; 80 (6): 755 – 757.pmid/8330167
6. Ranson JHC, Rifkind KM, Roses DF, et al. Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynaecol Obstet 1974; 139 (1): 69 – 81.
7. Larvin M, McMahon MJ. APACHE-II score for assessment and monitoring of acute pancreatitis. Lancet 1989; 2 (8586): 201 – 205.pmid/2568529
8. Wilson C, Heath DI, Imrie CW. Prediction of outcome in acute pancreatitis: a comparative study of APACHE-II clinical assessment and multiple factor scoring systems. Br J Surg 1990; 77 (11): 1260 – 1264.pmid/2253005
9. Balthazar EJ, Robinson DL, Megibow AJ, et al. Acute pancreatitis: value of CT in establishing prognosis. Radiology 1990; 174 (2): 331 – 336.pmid/2296641
10. Kemppainen E, Sainio V, Haapiainen R, et al. Early localization of necrosis by contrast enhanced computed tomography can predict outcome in severe acute pancreatitis. Br J Surg 1996; 83: 924 – 929.pmid/8813776
11. Pezilli R, Billi P, Miniero R, et al. Serum interleukin-6, interleukin-8, and beta 2-microglobulin in early assessment of severity of acute pancreatitis. Comparison with serum C-reactive protein. Dig Dis Sci 1995; 40 (11): 2341 – 2348.pmid/7587812
12. Cook AK, Breitschwerdt EB, Levine JF, et al. Risk factors associated with acute pancreatitis in dogs: 101 cases (1985–1990). J Am Vet Med Assoc 1993; 203 (5): 673 – 679.pmid/8407536
13. Ruaux CG, Atwell R. General practice attitudes to the treatment of spontaneous canine acute pancreatitis. Aust Vet Pract 1998; 28 (2): 67 – 73.
14. Ruaux CG. Pathophysiology of organ failure in severe acute pancreatits in dogs. Comp Cont Educ Pract Vet 2000; 22 (6): 531 – 542.
15. Salisbury SK, Lantz GC, Nelson RW, et al. Pancreatic abscess in dogs: six cases (1978–1986). J Am Vet Med Assoc 1988; 193 (9): 1104 – 1108.pmid/3198466
16. Edwards DF, Bauer MS, Walker MA, et al. Pancreatic masses in seven dogs following acute pancreatitis. J Am Anim Hosp Assoc 1990; 26: 189 – 198.
17. Smith SA, Biller DS. Resolution of a pancreatic pseudocyst in a dog following percutaneous ultrasonographic-guided drainage. J Am Anim Hosp Assoc 1998; 34: 515 – 522.pmid/9826289
18. VanEnkevort BA, O'Brien RT, Young KM. Pancreatic pseudocysts in 4 dogs and 2 cats: ultrasonographic and clinicopathologic findings. J Vet Intern Med 1999; 13: 309 – 313.pmid/10449220
19. Wolfsheimer KJ, Hedlund CS, Pechman RD. Pancreatic pseudocyst in a dog with chronic pancreatitis. Canine Practice 1991; 16 (1): 6 – 9.
20. Marchevsky AM, Yovich JC, Wyatt KM. Pancreatic pseudocyst causing extrahepatic biliary obstruction in a dog. Aust Vet J 2000; 78 (2): 99 – 101.pmid/10736669
21. Rutgers C, Herring DS, Orton EC. Pancreatic pseudocyst associated with acute pancreatitis in a dog: ultrasonographic diagnosis. J Am Anim Hosp Assoc 1985; 21: 411 – 416.
22. Hess RS, Saunders M, Van Winkle TJ, et al. Clinical, clinicopathologic, radiographic and ultrasonographic abnormalities in dogs with fatal acute pancreatitis: 70 cases (1986–1995). J Am Vet Med Assoc 1998; 213 (5): 665 – 670.pmid/9731261
23. Gullo L, Migliori M, Pezzilli R, et al. An update on recurrent acute pancreatitis: data from five European countries. Am J Gastroenterol 2002; 97 (8): 1959 – 1962.pmid/12190160
24. Sakorafas GH, Tsiotou AG. Etiology and pathogenesis of acute pancreatitis: current concepts. J Clin Gastroenterol 2000; 30 (4): 343 – 356.pmid/10875461
25. Hess RS, Kass PH, Shofer FS, et al. Evaluation of risk factors for fatal acute pancreatitis in dogs. J Am Vet Med Assoc 1999; 214 (1): 46 – 51.pmid/9887939
26. Haig TH. Pancreatic digestive enzymes: Influence of a diet that augments pancreatitis. J Surg Res 1970; 10 (12): 601 – 607.pmid/5494089
27. Lindsay S, Entenmann C, Chaikoff IL. Pancreatitis accompanying hepatic disease in dogs fed a high fat, low protein diet. Arch Pathol 1948; 45: 635 – 638.
28. Haig TH. Experimental pancreatitis intensified by a high fat diet. Surg Gynaecol Obstet 1970; 131: 914 – 918.pmid/5471544
29. Hofbauer B, Saluja AK, Lerch MM, et al. Intra-acinar activation of trysinogen during carulein-induced pancreatitis in rats. Am J Physiol 1998; 275 (2 Part 1): G352 – G362.pmid/9688663
30. Grady T, Saluja A, Kaiser A, et al. Edema and intrapancreatic trypsinogen activation precede glutathione depletion during caerulein pancreatitis. Am J Physiol 1996; 271 (1 Part 1): G20 – G26.pmid/8760102
31. Imrie CW, Benjamin IS, Ferguson JC, et al. A single-centre double blind trial of Trasylol therapy in primary acute pancreatits. Br J Surg 1978; 65 (5): 337 – 341.pmid/348250
32. Blamey SL, Imrie CW, O' Neill J, et al. Prognostic factors in acute pancreatitis. Gut 1984; 25 (12): 1340 – 1346.pmid/6510766
33. Knaus WA, Draper EA, Wagner DP, et al. APACHE-II: a severity of disease classification system. Crit Care Med 1985; 13 (10): 818 – 829.pmid/3928249
34. Khan AA, Parekh D, Cho Y, et al. Improved prediction of outcome in patients with severe acute pancreatitis by the APACHE II score at 48 hours after hospital admission compared with the APACHE II score at admission. Acute Physiology and Chronic Health Evaluation. Arch Surg 2002; 137 (10): 1136 – 1140.pmid/12361419
35. Porter KA, Banks PA. Obesity as predictor of severity in acute pancreatitis. Int J Pancreatol 1991; 10 (3–4): 247 – 252.pmid/1787336
36. Funnell IC, Bornman PC, Weakley SP, et al. Obesity: an important prognostic factor in acute pancreatitis. Br J Surg 1993; 80 (4): 484 – 486.pmid/8495317
37. Martinez J, Sanchez-Paya J, Palazon JM, et al. Obesity: a prognostic factor of severity in acute pancreatitis. Pancreas 1999; 19 (1): 15 – 20.pmid/10416686
38. Toh SKC, Walters J, Johnson CD. APACHE-O: a new predictor of severity in acute pancreatitis. Gut 1996; 38 (Suppl. 1): A35.
39. Osvaldt AB, Viero P, Borges da Costa MS, et al. Evaluation of Ranson, Glasgow, APACHE-II, and APACHE-O criteria to predict severity in acute biliary pancreatitis. Int Surg 2001; 86 (3): 158 – 161.pmid/11996072
40. Ruaux CG, Atwell RB. A severity score for spontaneous canine acute pancreatitis. Aust Vet J 1998; 76 (12): 804 – 808.pmid/9972431
41. De Beaux AC, Ross JA, Maingay JP, et al. Proinflammatory cytokine release by peripheral blood mononuclear cells from patients with acute pancreatitis. Br J Surg 1996; 83 (8): 1071 – 1075.pmid/8869305
42. De Beaux AC, Goldie AS, Ross JA, et al. Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis. Br J Surg 1996; 83 (3): 349 – 353.pmid/8665189
43. Imrie CW, McKay CJ. The scientific basis of medical therapy of acute pancreatitis. Could it work and is there a role for lexipafant? Gastroenterol Clin 1999; 28 (3): 591 – 599.pmid/10503138
44. Denham W, Norman J. The potential role of therapeutic cytokine manipulation in acute pancreatitis. Surg Clin North Am 1999; 79 (4): 767 – 781.pmid/10470326
45. Gudgeon AM, Heath DI, Hurley P, et al. Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis. Lancet 1990; 335 (8680): 4 – 8.pmid/1967341
46. Tenner S, Fernandez-del Castillo C, Warshaw A, et al. Urinary trypsinogen activation peptide (TAP) predicts severity in patients with acute pancreatitis. Int J Pancreatol 1997; 21 (2): 105 – 110.pmid/9209951
47. Leser HG, Gross V, Scheibenbogen C, et al. Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis. Gastroenterology 1991; 101 (3): 782 – 785.pmid/1907253
48. Heath DI, Cruickshank A, Gudgeon M, et al. Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut 1993; 34 (1): 41 – 45.pmid/7679365
49. Paajanen H, Laato M, Jaakkola M, et al. Serum tumor necrosis factor compared with C-reactive protein in the early assessment of severity of acute pancreatitis. Br J Surg 1995; 82 (2): 271 – 273.pmid/7749709
50. Karne S, Gorelik FA. Etiopathogenesis of acute pancreatitis. Surg Clinf North A 1999; 79 (4): 699 – 710.pmid/10470320
51. Sandberg AA, Borgstrom A. Early prediction of severity in acute pancreatitis. Is this possible? J Appl Physiol 2002; 3 (5): 116 – 125.pmid/12221326
52. Triester SL, Kowdley KV. Prognostic factors in acute pancreatitis. J Clin Gastroenterol 2002; 34 (2): 167 – 175.pmid/11782614
53. Hedstrom J, Sainio V, Kemppainen E, et al. Serum complex of trypsin 2 and alpha 1 antitrypsin as diagnostic and prognostic marker of acute pancreatitis: clinical study in consecutive patients. Br Med J 1996; 313 (7053): 333 – 337.pmid/8760740
54. Hedstrom J, Sainio V, Kemppainen E, et al. Urine trypsinogen-2 as a marker of acute pancreatitis. Clin Chem 1996; 42 (5): 685 – 690.pmid/8653892
55. Borgstrom A, Appelros S, Muller CA, et al. Role of activation peptides from pancreatic proenzymes in the diagnosis and prognosis of acute pancreatitis. Surgery 2002; 131 (2): 125 – 128.pmid/11854688
56. Mayer J, Rau B, Schoenberg MH, et al. Mechanism and role of trysinogen activation in acute pancreatitis. Hepatogastroenterology 1999; 46 (29): 2757 – 2763.pmid/10576341
57. Neoptolemos JP, Kemppainen EA, Mayer JM, et al. Early prediction of severity in acute pancreatitis by urinary trysinogen activation peptide: a multicentre study. Lancet 2000; 335 (9219): 1955 – 1960.
58. Hedstrom J, Korvuo A, Kenkimaki P, et al. Urinary trypsinogen-2 test strip for acute pancreatitis. Lancet 1996; 347 (9003): 729 – 730.pmid/8602003
59. Frossard JL. Trypsin activation peptide (TAP) in acute pancreatitis: from pathophysiology to clinical usefulness. J Appl Physiol 2001; 2 (2): 69 – 77.pmid/11867866
60. Mansfield CS, Jones BR. Plasma and urinary trypsinogen activation peptide in healthy dogs, dogs with pancreatitis and dogs with other systemic diseases. Aust Vet J 2000; 78 (6): 416 – 422.pmid/10920782
61. Appelros S, Petersson U, Toh S, et al. Activation peptide of carboxypeptidase B and anionic trypsinogen as early predictors of the severity of acute pancreatitis. Br J Surg 2001; 88 (2): 216 – 221.pmid/11167870
62. Appelros S, Thim L, Borgstrom A. Activation peptide of carboxypeptidase B in serum and urine in acute pancreatitis. Gut 1998; 42 (1): 97 – 102.pmid/9505893
63. Muller CA, Appelros S, Uhl W, et al. Serum levels of procarboxypeptidase B and its activation peptide in patients with acute pancreatitis and non-pancreatic diseases. Gut 2002; 51 (2): 229 – 235.pmid/12117885
64. Puolakkainen P, Valtonen V, Paananen A, et al. C-reactive protein and serum phospholipase A2 in the assessment and severity of acute pancreatitis. Gut 1987; 28: 764 – 771.pmid/3623221
65. Wilson C, Heads A, Shenkin A, et al. C-reactive protein, antiproteases, and complement factors as objective markers of severity in acute pancreatitis. Br J Surg 1989; 76: 177 – 181.pmid/2467718
66. Bulcher M, Malferthernier P, Schoetensack C, et al. Sensitivity of antiproteases, complement factors and C-reactive protein in detecting pancreatic necrosis. Results of a prospective clinical study. Int J Pancreatol 1986; 227 – 235.
67. Viedma JA, Perez-Mateo M, Agullo J, et al. Inflammatory response in the early prediction of severity in human acute pancreatitis. Gut 1994; 35 (6): 822 – 827.pmid/7517379
68. Burton SA, Honor DJ, Mackenzie AL, et al. C-reactive protein concentrations in dogs with inflammatory leukograms. Am J Vet Res 1994; 55 (5): 613 – 618.pmid/8067607
69. Conner JG, Eckersall PD. Acute phase response in the dog following surgical trauma. Res Vet Sci 1988; 45: 107 – 110.pmid/2464844
70. Liu Q, Djuricin G, Nathan C, et al. The effect of interleukin-6 on bacterial translocation in acute canine pancreatitis. Int J Pancreatol 2000; 27 (2): 157 – 165.pmid/10862515
71. Yamamoto S, Shida T, Honda M, et al. Serum C-reactive protein and immune responses in dogs inoculated with Bordetella bronchiseptica (phase 1 cells). Vet Res Commun 1994; 18 (5): 347 – 357.pmid/7863606
72. Martinez-Subiela S, Tecles F, Eckersall PD, et al. Serum concentrations of acute phase proteins in dogs with leishmaniasis. Vet Rec 2002; 150 (8): 241 – 244.pmid/11916025
73. Ruaux CG, Pennington HL, Worrall S, et al. Tumor necrosis factor-α at presentation in 60 cases of spontaneous canine acute pancreatitis. Vet Immunol Immunopathol 1999; 72 (3–4): 369 – 376.pmid/10628678
74. Hirota M, Nozawa F, Okabe A, et al. Relationship between plasma cytokine concentration and multiple organ failure in patients with acute pancreatitis. Pancreas 2000; 21 (2): 141 – 146.pmid/10975707
75. Kaufmann P, Tilz GP, Lueger A, et al. Elevated plasma levels of soluble tumor necrosis factor receptor (sTNFRp60) reflect severity of acute pancreatitis. Intens Care Med 1997; 23 (8): 808 – 809.
76. Balthazar E. Acute pancreatitis: assessment of severity with clinical and CT evaluation. Radiology 2002; 223 (3): 603 – 613.pmid/12034923
77. Piironen A. Severe acute pancreatitis: contrast-enhanced CT and MRI features. Abdom Imaging 2001; 26 (3): 225 – 233.pmid/11429945
78. Gloor B, Schmidtmann AB, Worni M, et al. Pancreatic sepsis: prevention and therapy. Best Pract Res Clin Gastroenterol 2002; 16 (3): 379 – 390.pmid/12079264
79. Szentkereszty Z, Kerekes L, Hallay J, et al. CT-guided percutaneous peripancreatic drainage therapy in acute necrotizing pancreatitis. Hepatogastroenterology 2002; 49 (48): 1696 – 1698.pmid/12397769
80. Kleine LJ, Hornbuckle WE. Acute pancreatitis: the radiographic findings in 182 dogs. Vet Radiol 1978; 19 (4): 102 – 106.
81. Nyland TG, Mulvany MH, Strombeck DR. Ultrasonic features of experimentally induced, acute pancreatitis in the dog. Vet Radiol 1983; 24 (6): 260 – 266.
82. Murtaugh RJ, Herring DS, Jacobs RM, et al. Pancreatic ultrasonography in dogs with experimentally induced acute pancreatitis. Vet Radiol 1985; 26 (1): 27 – 32.
83. Lamb CR, Simpson KW. Ultrasonographic findings in cholecystokinin-induced pancreatitis in dogs. Vet Radiol Ultrasound 1995; 36 (2): 139 – 145.
84. Nyland TG, Mattoon JS, Herrgesell EJ, et al. Pancreas, In: Nyland TG, Mattoon JS, eds. Small Animal Diagnostic Ultrasound. Philadelphia: W.B. Saunders Co.; 2002, pp. 144 – 157.
85. Probst A, Kneissl S. Computed tomography of the canine pancreas. Vet Radiol Ultrasound 2001; 42 (3): 226 – 230.pmid/11405263
86. Litzlbauer HD, Spillmann T, Rust S, et al. Computer-tomographie in der Pankreasdiagnostik beim Hund. In: FK-DVG 45th Annual Congress, Gießen, 1999, part Pankreas I.
87. Saunders HM. Ultrasonography of the pancreas. Probl Vet Med 1991; 3 (4): 583 – 603.pmid/1802271
88. Matos C, Winant C, Deviere J. Magnetic resonance pancreatography. Abdom Imaging 2001; 26 (3): 243 – 253.pmid/11429947
89. Logan JC, Callan MB, Drew K, et al. Clinical indications for use of fresh frozen plasma in dogs: 74 dogs (October through December 1999). J Am Vet Med Assoc 2001; 218 (9): 1449 – 1455.pmid/11345309
90. Wyncoll DL. The management of severe acute pancreatitis: an evidence-based review of the literature. Intens Care Med 1999; 25 (2): 146 – 156.pmid/10193540
91. Toouli J, Brooke-Smith M, Bassi C, et al. Working Party Report: guidelines for the management of acute pancreatitis. J Gastroenterol Hepatol 2002; 17 (Suppl.): S15 – S39.pmid/12000591
92. Abou-Assi S, O'Keefe SJD. Nutrition support during acute pancreatitis. Nutrition 2002; 18 (11/12): 938 – 943.pmid/12431714
93. Chen QP. Enteral nutrition and acute pancreatitis. World J Gastroenterol 2001; 7 (2): 185 – 192.pmid/11819758
94. Erstad BL. Enteral nutrition support in acute pancreatitis. Ann Pharmacother 2000; 34 (4): 514 – 521.pmid/10772439
95. Imrie CW, Carter CR, McKay CJ. Enteral and parenteral nutrition in acute pancreatitis. Best Pract Res Clin Gastroenterol 2002; 16 (3): 391 – 397.pmid/12079265
96. Sax HC, Warner BW, Talamini MA, et al. Early total parenteral nutrition in acute pancreatitis: lack of beneficial effects. Am J Surg 1987; 153 (1): 117 – 124.pmid/3099588
97. Kalfarentzos F, Kehagias J, Mead N, et al. Enteral nutrition is superior to parenteral nutrition in severe acute pancreatitis: results of a randomized prospective trial. Br J Surg 1997; 84 (12): 1665 – 1669.pmid/9448611
98. Windsor ACJ, Kanwar S, Li AGK, et al. Compared with parenteral nutrition, enteral feeding attenuates the acute phase response and improves disease severity in acute pancreatitis. Gut 1998; 42 (3): 431 – 435.
99. Olah A, Pardavi G, Belagyi T, et al. Early nasojejunal feeding in acute pancreatitis is associated with a lower complication rate. Nutrition 2002; 18 (3): 259 – 262.pmid/11882400
100. Al-Omran M, Groof A, Wilke D. Enteral versus parenteral nutrition for acute pancreatitis. Cochrane Database Syst Rev 2001; (2): CD002837.
101. Lippert AC, Fulton RB, Parr AM. A retrospective study of the use of total parenteral nutrition in dogs and cats. J Vet Intern Med 1993; 7 (2): 52 – 64.pmid/8501697
102. Freeman LM, Labato MA, Rush JE, et al. Nutritional support in pancreatitis: a retrospective study. J Vet Emerg Crit Care 1995; 5 (1): 32 – 41.
103. Swann HM, Sweet DC, Michel K. Complications associated with use of jejunostomy tubes in dogs and cats: 40 cases (1989–1994). J Am Vet Med Assoc 1997; 210 (12): 1764 – 1767.pmid/9187726
104. Reuter JD, Marks SL, Rogers QL, et al. Use of total parenteral nutrition in dogs: 209 cases (1988–1995). J Vet Emerg Crit Care 1998; 8 (3): 201 – 213.
105. Crowe DT, Devey JJ. Clinical experience with jejunostomy feeding tubes in 47 small animal patients. J Vet Emerg Crit Care 1997; 7 (1): 7 – 19.
106. Chan DL, Freeman LM, Labato MA, et al. Retrospective evaluation of partial parenteral nutrition in dogs and cats. J Vet Intern Med 2002; 16 (4): 440 – 445.pmid/12141306
107. Marks SL. The principles and practical application of enteral nutrition. Vet Clin North Am Small Anim Pract 1998; 28 (3): 677 – 708.pmid/9597721
108. Hardie EM, Armstrong J. Development of gastro-jejunal tube for the dog. J Nutr 1991; 121: S154.
109. Beger HG, Krautzberger W, Bittner R, et al. Results of surgical treatment of necrotizing pancreatitis. World J Surg 1985; 9 (6): 972 – 979.pmid/4082619
110. McFadden DW, Reber HA. Indications for surgery in severe acute pancreatitis. Int J Pancreatol 1994; 15 (2): 83 – 90.pmid/8071574
111. Beger HG, Rau B, Isenmann R, et al. Surgical treatment of acute pancreatitis. Ann Chir Gynaecol 1998; 87 (3): 183 – 189.pmid/9825061
112. Bulcher MW, Gloor B, Muller CA, et al. Acute necrotizing pancreatitis: treatment strategy according to the status of infection. Ann Surg 2000; 232 (5): 619 – 626.pmid/11066131
113. Ashley SW, Perez A, Pierce EA, et al. Necrotizing pancreatitis: contemporary analysis of 99 consecutive cases. Ann Surg 2001; 234 (4): 572 – 580.pmid/11573050
114. Hartwig W, Maksan SM, Foitzik T, et al. Reduction in mortality with delayed surgical therapy of severe pancreatitis. J Gastrointest Surg 2002; 6 (3): 481 – 487.pmid/12023003
115. Pederzoli P, Bassi C, Vesentini S, et al. A randomized multicenter trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem. Surg Gynecol Obstet 1993; 176 (5): 480 – 483.pmid/8480272
116. Golub R, Siddiqi F, Pohl D. Role of antibiotics in acute pancreatitis: a meta-analysis. J Gastrointest Surg 1998; 2 (6): 496 – 503.pmid/10457308
117. Powell JJ, Miles R, Siriwardena AK. Antibiotic prophylaxis in the initial management of severe acute pancreatitis. Br J Surg 1998; 85 (5): 582 – 587.pmid/9635800
118. Schmid S, Uhl W, Buchler MW. Protease–antiprotease interactions and the rationale for therapeutic protease inhibitors. Scand J Gastroenterol 1996; 219 (Suppl.): 47 – 50.pmid/8865472
119. Lasson A, Ohlsson K. Protease inhibitors in acute pancreatitis. Correlation between biochemical changes and clinical course. Scand J Gastroenterol 1984; 19 (6): 779 – 786.pmid/6083596
120. Murtaugh RJ, Jacobs RM. Serum antiprotease concentrations in dogs with spontaneous and experimentally induced pancreatitis. Am J Vet Res 1985; 46 (1): 80 – 83.pmid/2578757
121. Ruaux CG, Atwell RB. Levels of total α-macroglobulin and trypsin-like immunoreactivity are poor indicators of clinical severity in spontaneous canine acute pancreatitis. Res Vet Sci 1999; 67: 83 – 87.pmid/10425245
122. Leese T, West KP, Morton DB, et al. Fresh frozen plasma therapy in acute pancreatitis: an experimental study. Int J Pancreatol 1988; 3 (6): 437 – 447.pmid/3221106
123. Cushieri A, Wood RA, Cumming JR, et al. Treatment of acute pancreatitis with fresh frozen plasma. Br J Surg 1983; 70 (12): 710 – 712.pmid/6640250
124. Chen HM, Chen JC, Hwang TL, et al. Prospective and randomized study of gabexate mesilate for the treatment of severe acute pancreatitis with organ dysfunction. Hepatogastroenterology 2000; 47 (34): 1147 – 1150.pmid/11020900
125. Leese T, Holliday M, Heath D, et al. Multicentre clinical trial of low volume fresh frozen plasma therapy in acute pancreatitis. Br J Surg 1987; 74 (10): 907 – 911.pmid/2444309
126. Leese T, Holliday M, Watkins M, et al. A multicentre controlled clinical trial of high-volume fresh frozen plasma therapy in prognostically severe acute pancreatitis. Ann R Coll Surg Engl 1991; 73 (4): 207 – 214.pmid/1713753
127. Buchler MW, Malfertheiner P, Uhl W, et al. Gabeexate mesilate in human acute pancreatitis. German pancreatitis study group. Gastroenterology 1993; 104 (4): 1165 – 1170.pmid/8462805
128. Bassi C, Mangiante G, Falconi M, et al. Prophylaxis for septic complications in acute necrotizing pancreatitis. J Hepatobilliary Pancreat Surg 2001; 8: 211 – 215.pmid/11455481
129. Koch K, Drewelow B, Liebe S, et al. Pancreatic penetration of antibiotics. Chirurg 1991; 62 (4): 317 – 322.pmid/1860357
130. Trudel JL, Wittnich C, Brown RA. Antibiotics bioavailability in acute experimental pancreatitis. J Am Coll Surg 1994; 178 (5): 475 – 479.pmid/8167885
131. Mayer AD, McMahon MJ, Corfield AP, et al. Controlled clinical trial of peritoneal lavage for the treatment of severe acute pancreatitis. N Engl J Med 1985; 312 (7): 399 – 404.pmid/2578610
132. Ihse I, Evander A, Gustafson I, et al. Influence of peritoneal lavage on objective prognostic signs in acute pancreatitis. Ann Surg 1986; 204 (2): 122 – 127.pmid/2427042
133. Ranson JH, Berman RS. Long peritoneal lavage decreases pancreatic sepsis in acute pancreatitis. Ann Surg 1990; 211 (6): 708 – 716.pmid/2357134
134. Platell C, Cooper D, Hall JC. A meta-analysis of peritoneal lavage for acute pancreatitis. J Gastroenterol Hepatol 2001; 16 (6): 689 – 693.pmid/11422624
135. Bassi C, Briani G, Vesenti S, et al. Continuous peritoneal dialysis in acute experimental pancreatitis in dogs. Effect of aprotonin in the dialysate medium. Int J Pancreatol 1989; 5 (1): 69 – 75.pmid/2473149
136. Crisp S, Chew DJ, DiBartola SP, et al. Peritoneal dialysis in dogs and cats: 27 cases (1976–1987). J Am Vet Med Assoc 1989; 195 (9): 1262 – 1266.pmid/2584128
137. Yamauchi JI, Shibuya K, Sunamura M, et al. Cytokine modulation in acute pancreatitis. J Hepatobiliary Pancreat Surg 2001; 8: 195 – 203.
138. McKay C, Curran FJM, Sharples CE, et al. Prospective placebo-controlled randomized trial of lexipafant in predicted severe acute pancreatitis. Br J Surg 1997; 84 (9): 1239 – 1243.pmid/9313702
139. Abu-Zidan FM, Windsor JA. Lexipafant and acute pancreatitis: a critical appraisal of the clinical trails. Eur J Surg 2002; 168 (4): 215 – 219.pmid/12440758